Gadodiamide in Renal Transplant Patients: Effects on Renal Function and Usefulness as a Glomerular Filtration Rate Marker

Nephron

Volumn 72, Issue 2, 1996, Pages 212-217

  Berg, K J ^a   Lundby, B ^b   Reinton, V ^b   Nordal, K P ^a   Rootwelt, K ^a   Smith, H J ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b NYCOMED IMAGING AS   (Norway)

Author keywords

Gadodiamide; Kidney transplants; Nephrotoxicity; Pharmacokinetics

Indexed keywords

CREATININE; GADODIAMIDE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG EXCRETION; FECES; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA CLEARANCE; PRIORITY JOURNAL;

ADULT; AGED; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CONTRAST MEDIA; CREATININE; FEMALE; GADOLINIUM; GADOLINIUM DTPA; GLOMERULAR FILTRATION RATE; HALF-LIFE; HUMANS; INJECTIONS, INTRAVENOUS; IODINE RADIOISOTOPES; IOTHALAMIC ACID; KIDNEY; KIDNEY DISEASES; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID;

EID: 0030065941     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000188844     Document Type: Article

References (17)

1. van Wagoner M, O'Toole M, Worah D, Leese PT. Quay SC: A phase I clinical trial with gad-odiamide injection, a nonionic magnetic resonance imaging enhancement agent. Invest Radiol 1991;26:980-986.
2. Lundby B. Berg KJ. Lien HH, Aamdal S: A double-blind study to evaluate the tolerability of gadodiamide injection and its effects on renal function in patients undergoing cerebral magnetic resonance imaging. BrJ Radiol 1993: 66:871-876.
3. Svaland MG, Skalpe IO. Bakke SJ. Hald JK: A double-blind study to evaluate the efficacy and tolerability of a higher dose (0.3 mmol per kg bw) of gadodiamide injection as contrast medium for MRI. MAGMA 1993:1:169-175.
4. Leander P. Allard M. Caille JM. Golman K: Early effects of gadopentatc and iodinated contrast media on rabbit kidneys. Invest Radiol 1992:27:922-926.
5. Haustein J. Niendorf HP. Krestin G. Louton T, Schumann-Giamperi G. Clau B W. Junge W: Renal tolerance and tolerability of Gadolinum-DTPA/Dimeglumine in patients with chronic renal failure. Invest Radiol 1992:27:153-156.
6. Beilin M-F. Deray G. Assogba U. Auberton E. Ghany F, Dion-Voirin E. Jacobs C, Grellet J: Gd-DOTA: Evaluation of its tolerance in patients with chronic renal failure. Magn Reson Imaging 1992:10:115-118.
7. Choyke P. Austin HA. Frank JA, Girton ME. Diggs RL. Dwyer AJ. Miller LG. MacFarland H. Simond T: Hydrated clearance of gadolin-ium-DTPA as a measurement of glomerular filtration rate. Kidney Int 1992;41:1595-1598.
8. von Schnackenburg B. Dewey Ch. Lüning M, Wenig B. Scholz W: Dynamische MRT nach Gd-DTPA-Applikation bei Nièrentransplan-taten: Suszeptibilitäts-und T;-EITektc. RöFO 1990:153:702-705.
9. Smith H-J. Bakke SJ: MR angiography of in situ and transplanted renal arteries. Acta Radiol 1993:34:150-155.
10. Reinton V, Berg KJ. Svaland M, Andrew E, Normann PT. Rootwelt K: Pharmacokinetics of gadodiamide injection in patients with moderately impaired renal function. Acta Radiol 1994; 1:S56-S61.
11. Berg KJ. Kolmannskog F. Lillevold PE, Nordal KP. Ressent L. Rootwelt K, Svaland M: lopen-tol in patients with chronic renal failure: Its effect on renal function and its use as a glomerular filtration rate parameter. Scand J Clin Lab Invest 1992:52:27-33.
12. Sapirstein LA, Vidt DG. Mandel MJ. Hanusek G: Volumes of distribution and clearance of intravenously injected creatinine in the dog. Am J Physiol 1995;181:330-336.
13. Schumann-Giamperi G. Clau B W. Krestin GP: Pharmacokinetics and safety of Gd-DPTA in patients with impaired renal function: in: Contrast Media in MRI. Berlin, Medicom Publishing. 1990.
14. Svaland M. Kolmannskog F, Lillevold PF. Nordal K. Ressem V. Berg KJ: Pharmacokinetics of iopentol in patients with chronic renal failure. Acta Radiol 1992:33:482-484.
15. l25l-iothalamate an ideal marker for glomerular filtration? Kidney Int 1985;27:9-16.
16. 99mTc-DTPA and inulin. Am J Kidney Dis 1990:16: 224-235.
17. Berns A: Nephrotoxicity of contrast media. Kidney Int 1989:36:730-740.